Search Language:

中文(台灣) / Traditional Chinese | Use language selector above (below, on mobile) to search additional languages

See by:

open filter
  • Selected filters
  • x(New York)

2 items matching filters

Search Results

369915

Practice:

  • Corporate
  • M&A and Private Equity
  • Global Compliance & Regulatory
  • Capital Markets
  • Fintech
  • Blockchain and Cryptocurrency
  • Technology Companies Group
  • Real Estate
  • China

Jeff Zhang Partner Corporate, M&A and Private Equity

Beijing; New York

Jinsong (Jeff) Zhang is a partner of the M&A and Private Equity Group, splitting his time between Orrick’s Beijing and New York offices. Jeff represents Chinese and international clients from multiple industries, including financial institutions, Fintech, technology, health care and real estate, in a broad range of M&A, capital markets, corporate governance, regulatory and compliance matters.

Jeff is deeply experienced in representing both Chinese and international companies in cross-border public and private M&A, tender offers, privatizations, spin-offs and joint ventures.

He has a particular focus on advising Chinese companies (state-owned or private) and financial institutions on their outbound investments, regulatory and compliance matters in the United States. His clients cover a wide range of industries, including financial institutions, Fintech, technology, healthcare and real estate.

In addition, Jeff advises Chinese companies on international capital markets transactions, including SEC-registered offerings, private placements pursuant to Rule 144A, and listings in Hong Kong and the United States.

Having practiced for more than a decade in New York, and having served as General Counsel and Chief Compliance Officer of CITIC Securities USA, a SEC/FINRA-registered broker-dealer arm of China’s largest full-service investment bank, Jeff offers Chinese clients a unique perspective when advising on U.S. transactional and compliance matters.

Prior to joining Orrick, Jeff was a partner at King & Wood Mallesons in New York. Before his in-house position at CITIC Securities USA, he practiced at two leading global law firms in New York, Hong Kong, Beijing, and Shanghai for many years.

10311_740x360

Practice:

  • Intellectual Property
  • Mass Torts & Product Liability
  • Trade Secrets Litigation
  • IP Counseling & Due Diligence
  • Patents
  • Antitrust & Competition
  • International Trade & Compliance
  • White Collar, Investigations, Securities Litigation & Compliance
  • Cyber, Privacy & Data Innovation
  • Employment Law & Litigation
  • Copyright, Trademark & False Advertising
  • Automotive Technology & Mobility
  • China

Xiang Wang Partner Intellectual Property, Mass Torts & Product Liability

Beijing; New York

Dr. Xiang Wang is the Co-Chair of Orrick’s Global Advisory Board, Partner in Charge for Asia and the head of China IP practice, splitting his time between three offices: Shanghai, New York and Beijing, where he is the Managing Partner.

Xiang has extensive experience in assisting local and foreign-based multinational companies with all aspects of their IP rights in the U.S., China and Asia, including IP litigation and arbitration, patent, copyright and trademark infringements, Section 337 U.S. International Trade Commission (ITC) investigations, patent office proceedings including inter partes reviews (IPR), IP due diligence and portfolio counseling, industrial espionage, trade secrets misappropriation, mass torts and product liability, securities litigation, the Foreign Corrupt Practices Act (FCPA), the Alien Tort Statute (ATCA) and the Racketeer Influenced and Corrupt Organizations Act (RICO) investigations and compliance. These matters have implicated a vast array of technologies, from software and electronics to renewable energy and medical devices as well as agricultural and building materials, to name just a few. Xiang also works extensively on cybersecurity & data privacy issues for both Chinese and international clients.

Xiang has been particularly active in Chinese state-owned enterprises related U.S. litigation. Clients turn to his strategic and innovative advice thanks to the in-depth understanding of their business needs and political risks, and appreciate that he “understood the environment in the China legal system and can give nuanced advice”.

Xiang has developed the region’s premier IP practice based on his reputation as one of the few IP lawyers who has a doctorate in electrical and computer engineering, a Chinese Certificate of Laws and admission to practice law in New York, Indiana and before the U.S. Patent and Trademark Office. Due to its success in patent disputes in the U.S. and China, involving both foreign and Chinese companies, Orrick IP team was exclusively featured in a documentary film “Patent Wars” by the China Central Television (CCTV). 

Xiang is highly regarded for his practical legal advice that results from more than 10 years of experience at medical and electronic device businesses before becoming a lawyer. He also has received four U.S. medical-technology patents in his name.